OrthoPediatrics (KIDS) received FDA approval for the 3P Pediatric Plating Platform Small-Mini System, the second of several systems in the 3P family, the company announced.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KIDS:
- OrthoPediatrics announces FDA approval of 3P Pediatric Plating Platform
- OrthoPediatrics reports Q3 EPS (24c), consensus (26c)
- KIDS Upcoming Earnings Report: What to Expect?
- OrthoPediatrics price target lowered to $34 from $37 at Lake Street
- OrthoPediatrics price target lowered to $18 from $22 at Truist